43 embedded-system "https:" "https:" "https:" "https:" positions at Newcastle University
Sort by
Refine Your Search
-
Award Summary 100% fees covered, and a minimum tax-free annual living allowance of £20,835 (2025/26 UKRI rate). Overview The Award This PhD project is a partnership between Scottish Power and
-
2022. The problem? Manually giving well-considered consent to every data use in real time is impossible. The solution? Autonomous agent systems that protect your privacy efficiently, transparently, and
-
also be provided. Overview High-purity quartz is a critical raw material for advanced industries such as semiconductors and optical fibres. The purification of quartz typically involves high-temperature
-
pathways. The goal is to design bio-instructive materials that actively direct immune and bone cells toward regeneration. These will be characterised using AFM and rheology, followed by immune–osteogenic co
-
Award Summary 100% fees (UK Home only), a minimum tax-free annual living allowance at the 2026/27 UKRI rate (note that the 2025/26 rate is £20,780), and a research training support grant of £20,000
-
challenges: Data management across the edge cloud continuum means tracking the origin, ownership, and transformations of data: where it comes from (source), where it is stored, who controls access and usage
-
. Targeted covalent inhibitors (TCIs) have vast potential to open new therapeutic avenues for undruggable targets but is currently limited by a lack of novel warheads and screening libraries. This project will
-
to lysine-TCI development in drug discovery. These optimised warheads will be incorporated into known inhibitors and tested against the relevant protein as a proof of concept. This is an opportunity to join a
-
, and travel related to the project. Overview ReNU+ is a unique and ambitious programme that will train the next-generation of doctoral carbon champions who are renowned for research excellence and
-
testing potential drug candidates in high-throughput. One of the barriers to the discovery of new medicines is the time taken to design, synthesise and test compounds through multiple cycles of optimisation